Schwarzlose-Schwarck, Sandra
Reinwald, Mark
Bauer, Torsten
Hentschel, Florian
Kiderlen, Til
Zapf, Dorinja
Herbst, Victor
Lüth, Stefan
Krieger, David
Dammermann, Werner
Funding for this research was provided by:
Medizinische Hochschule Brandenburg CAMPUS GmbH
Article History
Received: 23 November 2023
Accepted: 30 January 2025
First Online: 7 February 2025
Declarations
:
: Our study adhered to the Declaration of Helsinki regarding research carried out on humans and/or human data. The study was approved by the Ethics Committee of the Brandenburg Chamber of Physicians (S20(a)/2016) as well as the Berlin Chamber of Physicians (Eth-V-ZK/17) and all patients gave informed consent for the participation.
: Not applicable.
: D.Z. and V.H. are employed by EUROIMMUN, a manufacturer of diagnostic reagents and co-owner of patents related to serological assays for the diagnosis of infectious diseases and the detection of immunity as a result of vaccination. EUROIMMUN provided kits for analyses at discounted rates. The other authors declare that they have no competing interests.